Beck Bode, LLC Novo Nordisk A S Transaction History

Beck Bode, LLC

  • $529 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 09, 2023
BUY
$155.98 - $172.65 $60,052 - $66,470
385 Added 11.11%
3,850 $623,000
Q1 2023

May 03, 2023
SELL
$132.34 - $159.14 $178,129 - $214,202
-1,346 Reduced 27.98%
3,465 $551,000
Q4 2022

Feb 07, 2023
BUY
$102.55 - $135.33 $493,368 - $651,072
4,811 New
4,811 $651,000

Others Institutions Holding NVO

# of Institutions
1,956
Shares Held
320M
Call Options Held
5.49M
Put Options Held
7.78M
View Full List

About NOVO NORDISK A S

NVO Quotes by TradingView
  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $244B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Beck Bode, LLC Portfolio

Follow Beck Bode, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Beck Bode, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Beck Bode, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email